Skip to main content
Vitrolife AB (publ) (STO:VITR)
Sweden flag Sweden · Delayed Price · Currency is SEK
141.30
+2.10 (1.51%)
At close: Dec 5, 2025

Vitrolife AB Revenue

Vitrolife AB had revenue of 835.00M SEK in the quarter ending September 30, 2025, a decrease of -3.69%. This brings the company's revenue in the last twelve months to 3.51B, down -1.35% year-over-year. In the year 2024, Vitrolife AB had annual revenue of 3.61B with 2.76% growth.

Revenue (ttm)
3.51B
Revenue Growth
-1.35%
P/S Ratio
5.46
Revenue / Employee
3.19M
Employees
1,169
Market Cap
19.14B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.61B97.00M2.76%
Dec 31, 20233.51B278.00M8.60%
Dec 31, 20223.23B1.55B92.39%
Dec 31, 20211.68B435.43M34.96%
Dec 31, 20201.25B-234.56M-15.85%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 27.85B
Getinge AB 35.85B
Sectra AB 3.37B
Camurus AB 2.35B
Medicover AB 25.67B
Asker Healthcare Group AB 16.41B
BioArctic AB 1.92B
AddLife AB 10.53B
Revenue Rankings

Vitrolife AB News

More News